Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
about
Characterization of uncultivable bat influenza virus using a replicative synthetic virusRotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonismAntiviral response in pandemic influenza virusesMaking better influenza virus vaccines?Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virusRotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genesLive attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenzaViral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsDevelopment of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesRecent progress in structure-based anti-influenza drug designCapsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene ExpressionStructural basis for suppression of a host antiviral response by influenza A virusReverse Genetics Approaches for the Development of Influenza VaccinesInfluenza: old and new threatsInfluenza A virus attenuation by codon deoptimization of the NS gene for vaccine developmentSublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in miceA pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizationsPlasmid-only rescue of influenza A virus vaccine candidates.Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenzaSwitch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.Host defense mechanism-based rational design of live vaccineInfluenza A virus PB1-F2 protein contributes to viral pathogenesis in miceModel of influenza A virus infection: dynamics of viral antagonism and innate immune response.Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus.Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.Influenza vaccines: a moving interdisciplinary field.Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984.NS-based live attenuated H1N1 pandemic vaccines protect mice and ferretsCross-protective immunity to influenza A viruses.A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.The influenza virus NS1 protein as a therapeutic target.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Current cell-based influenza vaccine production technology as pandemic contingency.Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunityVaccine development for protecting swine against influenza virus.
P2860
Q21089589-CDBA0FB5-B1D9-4EFC-B6EE-7736434EFCC4Q21090517-F13E23B6-9216-4FF0-ABCB-ADB067D6AAB1Q22305645-6D5E1E57-918D-4867-BBE6-D1884567128EQ22305647-9226666B-872A-4EB6-882E-DA63A806CEA4Q24311228-F3394D3D-0B75-4B99-B74A-BB2A34A6A726Q24555785-D50EB469-D7FF-4E4A-B947-8A17925EEF35Q24598177-278CB9B8-C1F2-469C-91F1-C27C1308EC7DQ24652088-1881B519-3CF7-4D9D-A648-7B4009699A5AQ26745547-AD1E494D-3E2E-45B8-8BEB-0C02E1E3BB1CQ26782411-10D703BA-FA94-429A-B848-C89FAFFB39EDQ26863710-0242BB32-4D3F-4D51-A423-6B8481045A63Q27478382-D02E897E-F9D7-4D02-AA2B-ADB29F8473DEQ27651800-86062A38-FEC8-43B1-B8E4-5F9F5C66EECCQ28076140-821AA8AD-2DDB-4863-8864-A6992E8B49AEQ28296381-F0E67EE3-D34B-468F-8159-6329FA919D88Q28395006-B585C86B-9AE7-4558-B8ED-1ABFE477B965Q28727930-B25A18B8-4B79-43F5-9A07-2FD1F3C80B0AQ28749671-164AF7B0-7570-4D37-9064-B655084F6D92Q30329368-3AB50C88-9239-4F2D-9E97-53F67E9E9A08Q30331304-F64F3230-0627-440B-897C-789A18405CB4Q30354127-5E24CD39-BD92-46C2-844D-C03FD1D75DB7Q30354189-527F1CD7-6973-4184-84D8-E1FA31BBD93EQ30355968-2ABE8DDB-6462-4BA7-88A0-6AEAE436C24BQ30359771-2D5E3347-88C5-4F99-A305-CFCADE1FF6DBQ30360869-B9D1265B-7FE9-49A1-AD5C-66A804A36C1EQ30363578-38EBAB3F-0841-42BD-95C3-2263E23A89E6Q30366819-D85D459B-5022-48C2-89C8-815892478D0AQ30367695-57619382-79C1-4037-840B-E4292D07A71AQ30371054-F6D8E745-F481-4EFB-B0DD-6FC398E0E3B3Q30373784-78D45058-5281-4A23-ACAD-87ECCF40B95BQ30377447-AA97E85B-BACD-4F83-8B94-BCA933C805E6Q30385956-6AAEF1BB-959F-4105-B6BA-715DC67B1D48Q30394706-8FEEA375-ABDD-4F5C-ABE0-FC29A565402BQ30396399-62971254-449D-4BEA-ADFE-01D52299FFEAQ30402334-A928E0BA-00CD-47B2-862F-493BC62A620BQ30407133-4D020F1B-62CC-4042-BD85-C097D72D3AE0Q30407424-29461D2F-CB53-4D68-901B-A1936B55DBD9Q30414391-03C6465B-93E2-4A05-8F88-CD1976011160Q30421682-9195B581-DC8C-4E38-857A-8D0E7150984AQ30424943-748FE56D-EC42-4A87-A826-B2FA13FC5AD0
P2860
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
@ast
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
@en
type
label
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
@ast
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
@en
prefLabel
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
@ast
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
@en
P2093
P2860
P356
P1476
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
@en
P2093
García-Sastre A
O'Neill RE
Salvatore M
P2860
P304
P356
10.1073/PNAS.070525997
P407
P50
P577
2000-04-01T00:00:00Z